US10226496B2 – March 12, 2019 – Topical treatments incorporating Cannabis sp. derived botanical drug product

Please complete the required fields.




Inventors :

Ronald D. Sekura; Roscoe M. Moore

Owner :

Sekura, Ronald D. Moore, Roscoe M.

Application Number :

US15914064

Document Number :

US10226496B2

Priority Date :

March 7, 2018

Filing Date :

March 7, 2018

Date of Grant/ Publication :

March 12, 2019

Class :

A61K36 / 00; A61K36 / 185; A61K31 / 352; A61K31 / 573; A61K31 / 085; A61K31 / 245; A61K31 / 047; A61K31 / 235; A61K31 / 045; A61K36 / 61; A61K9 / 00; A61K45 / 06; A61K31 / 05; A61K31 / 12; A61K31 / 618; A61K47 / 12; A61K9 / 06; A61K9 / 08; A61K47 / 44; A61K8 / 49; A61Q5 / 00; A61Q5 / 02; A61Q19 / 00; A61P17 / 06

Abstract

A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of tetrahydrocannabinol, cannabidiol, or both in the topical formulation is greater than 2 milligrams per kilogram.

Claim(s)

1. A topical formulation, consisting essentially of: an extract of cannabis sativa or cannabis indica ; and at least one component selected from the group consisting of benzoyl peroxide, oxybenzone, octocrylene, octyl methoxycinnamate, ethylhexyl salicylate, and avobenzone, present in an amount of at least 0.1 wt % in the topical formulation, wherein a concentration of at least one selected from the group consisting of tetrahydrocannabinol and cannabidiol in the topical formulation is greater than 2 milligrams per kilogram, and wherein the topical formulation is obtained by dispersing the extract of cannabis sativa or cannabis indica in a water-in-oil emulsion, an oil-in-water emulsion, a wax-in-oil base, an oil-in-wax base, or a liniment consisting essentially of the at least one component selected from the group consisting of benzoyl peroxide, oxybenzone, octocrylene, octyl methoxycinnamate, ethylhexyl salicylate, and avobenzone.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login